TASIA BRADFORD: Open Payments
NPI 1366999195 · SYLACAUGA, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,388 in 82 payments from 19 companies in 2025. Trend: 2023 $1,579 · 2024 $1,662 · 2025 $1,388
Food & beverage: $1,388
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 13 | $296 |
| Bayer Healthcare Pharmaceuticals Inc. | 9 | $232 |
| Amgen Inc. | 16 | $141 |
| ABBVIE INC. | 14 | $136 |
| Novo Nordisk Inc | 4 | $82 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $79 |
| Lilly USA, LLC | 3 | $59 |
| Exact Sciences Corporation | 3 | $48 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $45 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $42 |
Products named: Kerendia, FARXIGA, OTEZLA, JARDIANCE, VRAYLAR, Ozempic, UBRELVY, Cologuard Collection Kit.
Industry payments across AL — which companies pay providers there.
